Who owns ADIAL PHARMACEUTICALS INC?
- Ticker: ADIL
- CUSIP Number: 00688a304
Tip: Access positions for across all investors
Analyze quarterly positions in Adial Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Adial Pharmaceuticals stock
Who bought or sold ADIAL PHARMACEUTICALS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Geode Capital Management | 24k | $43k | 100% | Mar 2026 |
|
| Vanguard Fiduciary Trust | 5.9k | $11k | 100% | Mar 2026 |
|
| Manchester Capital Management | 1.9k | $3.4k | 100% | Mar 2026 |
|
| BlackRock | 1.1k | $2.0k | 100% | Mar 2026 |
|
| UBS Group | 542.00 | $970.017400 | 100% | Mar 2026 |
|
| Vanguard Capital Management | 361.00 | $646.009500 | 100% | Mar 2026 |
|
| Morgan Stanley | 50.00 | $90.000000 | 100% | Mar 2026 |
|
| SBI Securities | 47.00 | $83.998400 | 100% | Mar 2026 |
|
| Caitong International Asset Management | 15.00 | $27.000000 | 100% | Mar 2026 |
|
| Wells Fargo & Company | 6.00 | $10.999800 | 100% | Mar 2026 |
|
| Northwestern Mutual Wealth Management Company | 4.00 | $7.000000 | 100% | Mar 2026 |
|
| Harbour Investments | 3.00 | $5.000100 | 100% | Mar 2026 |
|
| Abound Wealth Management | 1.00 | $2.000000 | 100% | Mar 2026 |
|